U.S. pharma giant copyright scrapped two experimental weight loss supplements last 12 months—a once-day-to-day tablet, lotiglipron, on account of elevated liver enzymes in addition to a two times-daily pill, danuglipron, resulting from strong Uncomfortable side effects—but CEO Albert Bourla has mentioned the company is set to “Enjoy and gain�